UNH · 10-Q · 2026Q2 · Full report

Acquisition / Partnership / Divestiture

UNITEDHEALTH GROUP INC · 2026-08-10 · Importance 47 · Surprise 60 · In source text

The company’s 2025 strategic review generated a $39 million net portfolio-divestiture loss in the second quarter of 2026 and a $191 million net gain for the first six months. Six-month segment impacts included a $524 million gain at Optum Insight and an $8 million gain at Optum Rx, partly offset by a $341 million loss at Optum Health. In the first quarter of 2026, UnitedHealth Group agreed to acquire an unnamed health care company for $3.0 billion and completed the transaction on July 2, 2026, paying $1.5 billion in cash with $1.5 billion due within one year. Cash received from dispositions and other strategic transactions totaled $1.091 billion during the first six months, while cash paid for acquisitions and other transactions was $98 million.

Key facts

• In the first quarter of 2026 the company entered into an agreement to acquire a company in the health care sector for $3.0 billion; on July 2, 2026 the acquisition was completed for $1.5 billion in cash with the remaining $1.5 billion payable within one year. source
• Net portfolio divestitures resulted in a net loss of $39 million for the three months ended June 30, 2026 and a net gain of $191 million for the six months ended June 30, 2026. source
• Second quarter net portfolio divestiture impacts by segment consisted of net losses of $35 million at Optum Health and $4 million at Optum Insight. source
• Year-to-date net portfolio divestiture impacts consisted of gains of $524 million at Optum Insight and $8 million at Optum Rx, partially offset by a net loss of $341 million at Optum Health. source

Impact estimates